Axon Enterprise, Inc $AXON Shares Acquired by Oregon Public Employees Retirement Fund

Oregon Public Employees Retirement Fund increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 39.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,945 shares of the biotechnology company’s stock after acquiring an additional 2,533 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Axon Enterprise were worth $6,419,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vestor Capital LLC grew its position in Axon Enterprise by 438,636.3% during the 2nd quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company’s stock worth $690,170,000 after purchasing an additional 833,409 shares during the last quarter. Norges Bank purchased a new stake in shares of Axon Enterprise in the second quarter valued at about $637,806,000. McElhenny Sheffield Capital Management LLC acquired a new stake in shares of Axon Enterprise during the second quarter worth about $255,833,000. Vanguard Group Inc. grew its holdings in shares of Axon Enterprise by 3.5% during the second quarter. Vanguard Group Inc. now owns 8,937,260 shares of the biotechnology company’s stock worth $7,399,515,000 after buying an additional 305,252 shares during the last quarter. Finally, 1832 Asset Management L.P. grew its holdings in shares of Axon Enterprise by 129.2% during the second quarter. 1832 Asset Management L.P. now owns 536,420 shares of the biotechnology company’s stock worth $444,124,000 after buying an additional 302,420 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on AXON shares. Needham & Company LLC reaffirmed a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. UBS Group dropped their target price on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. JMP Securities restated a “market outperform” rating and set a $825.00 price target on shares of Axon Enterprise in a research note on Monday, September 29th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Finally, Piper Sandler lowered their price objective on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $805.71.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $631.69 on Friday. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. The stock has a 50 day simple moving average of $572.86 and a 200-day simple moving average of $688.07. The company has a market cap of $49.85 billion, a price-to-earnings ratio of 199.90, a price-to-earnings-growth ratio of 19.89 and a beta of 1.41. Axon Enterprise, Inc has a 12-month low of $469.24 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a net margin of 10.05% and a return on equity of 4.29%. The business had revenue of $710.64 million during the quarter, compared to analysts’ expectations of $704.83 million. The firm’s quarterly revenue was up 30.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.45 earnings per share. On average, equities analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Activity at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Wednesday, January 7th. The shares were sold at an average price of $619.01, for a total transaction of $6,190,100.00. Following the transaction, the chief executive officer directly owned 3,100,997 shares of the company’s stock, valued at $1,919,548,152.97. This represents a 0.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Brittany Bagley sold 2,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the completion of the sale, the chief financial officer owned 103,501 shares of the company’s stock, valued at $60,030,580. This trade represents a 1.90% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 60,540 shares of company stock worth $34,684,738. 4.40% of the stock is currently owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.